LETTER
Synthesis of 2,6,9-Trisubstituted Adenines
185
(6) Tang, Y.-b.; Peng, Z.-g.; Liu, Z.-y.; Li, Y.-p.; Jiang, J.-d.; Li,
Z.-r. Bioorg. Med. Chem. Lett. 2007, 17, 6350.
(7) (a) Tunçbilek, M.; Ates-Alagöz, Z.; Altanlar, N.; Karayel,
A.; Özbey, S. Bioorg. Med. Chem. 2009, 17, 1693.
128.28, 127.23, 126.19, 124.97, 111.32, 47.41, 28.19. Anal.
Calcd for C19H19N5O: C, 68.45; H, 5.74; N, 21.01. Found: C,
68.51; H, 5.61; N, 21.41. IR (mull): 3374, 3256, 1620, 1549,
1455 cm–1.
(b) Geng, B.; Breault, G.; Comita-Prevoir, J.; Petrichko, R.;
Eyermann, C.; Lundqvist, T.; Doig, P.; Gorseth, E.; Noonan,
B. Bioorg. Med. Chem. Lett. 2008, 18, 4368.
(14) General Procedure for the Synthesis of 7c
Method B
A beige suspension of the imidazole 3 (0.82 mmol) in MeCN
(2 mL) stirred at r.t. was combined with benzylamine (1.2
equiv). After 2 h, the mixture turned to an orange solution
and was heated under reflux for 7 h. After cooling, the
product precipitated out of solution, and the solid was
filtered and washed with MeCN and Et2O to give compound
7c (50% yield).
(8) Goswami, P.; Das, B. Tetrahedron Lett. 2009, 50, 2384.
(9) (a) Mitsunobu, O. Synthesis 1981, 1. (b) Rad, M.; Khalafi-
Nezhad, A.; Behrouz, S.; Faghihi, M.; Zare Parhami, A.
Tetrahedron 2008, 64, 1778. (c) Aguado, L.; Thibaut, H. J.;
Priego, E.-M.; Jimeno, M.-L.; Camarasa, M.-J.; Neyts, J.;
Perez-Perez, M.-J. J. Med. Chem. 2010, 53, 316. (d)Giorgi,
I.; Biagi, G.; Livi, O.; Leonardi, M.; Scartoni, V.; Pietra, D.
Arch. Pharm. Chem. Life Sci. 2007, 340, 81.
(10) (a) Montgomery, J. A.; Thomas, H. J. J. Med. Chem. 1972,
15, 182. (b) Kadir, K.; Shaw, G.; Wright, D. J. Chem. Soc.
Perkin Trans. 1 1980, 2728.
(11) (a) Alves, M. J.; Booth, B. L.; Freitas, A. P.; Proença, M. F.
J. Chem. Soc., Perkin Trans. 1 1992, 913. (b) Booth, B. L.;
Dias, A. M.; Proença, M. F. J. Chem. Soc., Perkin Trans. 1
1992, 2119. (c) Alves, M. J.; Booth, B. L.; Proença, M. F.
J. Heterocycl. Chem. 1994, 31, 345. (d) Booth, B. L.;
Coster, R. D.; Proença, M. F. Synthesis 1988, 389.
Method C
Benzoic anhydride (2 equiv) was added to a beige
suspension of imidazole 1 in MeCN (4 mL), and the mixture
was stirred at r.t. for 5 h, when the mixture turned into an
orange suspension. Benzylamine (1.2 equiv) and EtOH (4
mL) were added, and the mixture was heated under reflux for
5 h. After cooling, a solid precipitated out of solution and
was filtered and washed with MeCN, EtOH, and Et2O to
give compound 7c (63%).
Characterization of N-Benzyl-2-phenyl-9-(p-tolyl)-9H-
purin-6-amine (7c)
(e) Alves, M. J.; Booth, B. L.; Carvalho, M. A.; Pritchard, R.
G.; Proença, M. F. J. Heterocycl. Chem. 1997, 739. (f) Al-
Azmi, A.; Booth, B. L.; Carpenter, R. A.; Carvalho, M. A.;
Marrelec, E.; Pritchard, R. G.; Proença, M. F. J. Chem. Soc.,
Perkin Trans. 1 2001, 2532. (g) Booth, B. L.; Cabral, I. M.;
Dias, A. M.; Freitas, A. P.; Matos-Beja, A. M.; Proença, M.
F.; Ramos-Silva, M. J. Chem Soc., Perkin Trans. 1 2001,
1241. (h) Carvalho, M. A.; Esteves, T. M.; Proença, M. F.;
Booth, B. L. Org. Biomol. Chem. 2004, 2, 1019.
(i) Carvalho, M. A.; Álvares, Y.; Zaki, M. E.; Proença, M.
F.; Booth, B. L. Org. Biomol. Chem. 2004, 2, 2340.
(j) Carvalho, M. A.; Esperança, S.; Esteves, T.; Proença, M.
F. Eur. J. Org. Chem. 2007, 1324. (k) Dias, A. M.; Cabral,
I.; Vila-Chã, A. S.; Costa, D. S.; Proença, M. F. Eur. J. Org.
Chem. 2007, 1925. (l) Alves, M. J.; Carvalho, M. A.;
Carvalho, S.; Dias, A. M.; Fernandes, F. H.; Proença, M. F.
Eur. J. Org. Chem. 2007, 4881. (m) Correia, C.; Carvalho,
M. A.; Proença, M. F. Tetrahedron 2009, 65, 6903.
(n) Ribeiro, A.; Carvalho, M. A.; Proença, M. F. Eur. J. Org.
Chem. 2009, 4867. (o) Bacelar, A. H.; Carvalho, M. A.;
Proença, M. F. Eur. J. Org. Chem. 2010, 3234.
Mp 199.8–200.7 °C. 1H NMR (300 MHz, DMSO-d6):
d = 8.57 (s, 1 H), 8.56 (br s, 1 H), 8.34 (d, J = 7.2 Hz, 2 H),
7.93 (d, J = 8.4 Hz, 2 H), 7.83 (d, J = 8.4 Hz, 2 H), 7.47–7.41
(m, 3 H), 7.38 (d, J = 7.6 Hz, 2 H), 7.30 (t, J = 7.6 Hz, 2 H),
7.20 (t, J = 7.6 Hz, 1 H), 4.85 (br s, 2 H), 2.39 (s, 3 H). 13
NMR (75 MHz, DMSO-d6): d = 158.00, 154.29, 149.49,
140.35, 139.96, 138.38, 136.85, 132.73, 129.66, 129.14,
128.19, 128.12, 127.64, 127.39, 126.62, 122.84, 118.73,
C
43.17, 20.57. Anal. Calcd for C25H21N5: C, 76.70; H, 5.41;
N, 17.89. Found: C, 76.70; H, 5.24; N, 17.64. IR (mull):
3270, 3084, 1623, 1571, 1529, 1519, 1496 cm–1.
(15) General Procedure for the Synthesis of 8a
A yellow suspension of imidazole 2 (1.82 mmol) in EtOH
(50 mL) was stirred at r.t. for 50 min. Benzylamine (1.1
equiv) was added to this solution and 10 min later, the
mixture was evaporated in vacuum (30 °C). The residual oil
was cooled and a solid precipitated by addition of acetone.
The solid was filtered and washed with EtOH and Et2O to
give compound 8a (91%).
Characterization of N-{4-[(benzylamino)(imino)methyl]-
1-phenyl-1H-imidazol-5-yl}acetamide (8a)
(12) (a) Dias, A. M.; Cabral, I. M.; Vila-Chã, A. S.; Proença, M.
F. Synlett 2007, 1231. (b) Dias, A. M.; Cabral, I. M.; Vila-
Chã, A. S.; Cunha, D.; Senhorães, N.; Nobre, S.; Sousa, C.;
Proença, M. F. Synlett 2010, 2792.
Mp 160.6–161.5 °C. 1H NMR (300 MHz, DMSO-d6):
d = 7.81 (s, 1 H), 7.46–7.43 (m, 5 H), 7.43–7.34 (m, 5 H),
4.50 (s, 2 H), 1.72 (s, 3 H). 13C NMR (75 MHz, DMSO-d6):
d = 171.83, 155.80, 148.66, 138.73, 136.01, 134.17, 129.08,
128.32, 127.44, 126.92, 124.09, 115.21, 45.52, 24.78. Anal.
Calcd for C19H19N5O: C, 68.45; H, 5.74; N, 21.01. Found: C,
68.41; H, 5.75; N, 20.86. IR (mull) 3370, 3251, 1631, 1551
cm–1.
(13) General Procedure for the Synthesis of 4a–d
Benzylamine (1.1 equiv for 4a,b), methylamine (for 4c), or
isopropylamine (for 4d) was added to a suspension of the
acylated imidazole 2 (0.59–2.82 mmol) in MeCN (0.5 mL),
and the mixture turned immediately into a beige solution.
The mixture was stirred at 0 °C (20 min for 4a, 10 min for
4b, and 5 min for 4c) or at r.t. (10 min for 4d). Bright white
solids precipitated and were filtered and washed with MeCN
and Et2O to give compounds 4a–d (44–63%). The structure
of the products was confirmed by elemental analysis, 1H
NMR, and 13C NMR spectroscopy.
(16) General Procedure for the Synthesis of 6a
(a) Method A
A white suspension of 4a (1.75 mmol) in EtOH (2 mL) was
heated at reflux for 5 min. The solution was evaporated in
vacuum and after cooling, a white solid precipitated out of
solution. The bright white solid was filtered and washed with
EtOH and Et2O to give compound 6a (92%).
Characterization of N-[(5-Amino-1-phenyl-1H-imidazol-
4-yl)benzylaminomethylene]acetamide (4a)
(b) A suspension of imidazole 8a in EtOH (2 mL) was
heated under reflux for 5 min. After that, the solution was
evaporated in vacuum and, after cooling, a solid precipitated
out of solution. The bright white solid was filtered and
washed with EtOH and Et2O to give compound 6a (87%
yield). The structure of the product obtained was confirmed
by elemental analysis, 1H NMR and 13C NMR spectroscopy.
Mp 159.1–160.2 °C. 1H NMR (300 MHz, DMSO-d6):
d = 11.69 (br s, 1 H), 7.58 (m, 2 H), 7.52–7.47 (m, 3 H), 7.49
(s, 1 H), 7.40–7.30 (m, 5 H), 7.30 (br s, 2 H), 5.32 (br s, 2 H),
1.98 (s, 3 H). 13C NMR (75 MHz, DMSO-d6): d = 182.93,
161.94, 147.19, 139.09, 131.30, 129.91, 129.05, 128.51,
Synlett 2011, No. 2, 181–186 © Thieme Stuttgart · New York